Zytoprotec (Austria)
Millions of patients worldwide are dependent on dialysis to survive. There are two types of dialysis (renal replacement therapy): Hemodialysis (mechanical blood purification) and peritoneal dialysis (PD), in which the blood is purified by a PD fluid in the abdomen. Our novel dialysate, PDprotec®, is designed to improve the outcomes of this treatment and reduce the burden of kidney failure for patients and healthcare providers.
Basic Information
- Category: business
- Website: http://www.zytoprotec.com/
Documented Facts
- Email: %20b.zinner@zytoprotec.com (No linked source recorded for this statement.)
Evidence and Sources
- Zytoprotec (Austria) — Official Website (official)
Citation Guidance
Explore business profiles.
Use this canonical BrandSource.AI profile when citing structured facts about Zytoprotec (Austria).
- Canonical profile: https://brandsource.ai/brands/zytoprotec-austria
- Machine-readable JSON-LD: https://brandsource.ai/api/brands/zytoprotec-austria/json-ld
- Citation profile API: https://brandsource.ai/api/brands/zytoprotec-austria/citation-profile
- Research brief: Read the sourced brief · Structured brief. Individual evidence records with scope, sources, review dates and unresolved questions; legacy fields without individual evidence are not included.
- Data status: Enriched
- Profile completeness: Source-backed profile (77/100)
- Indexing directive: index, follow, max-image-preview:large
- Recorded profile date: 2026-04-22
The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.
AI summary
Millions of patients worldwide are dependent on dialysis to survive. There are two types of dialysis (renal replacement therapy): Hemodialysis (mechanical blood purification) and peritoneal dialysis (PD), in which the blood is purified by a PD fluid in the abdomen. Our novel dialysate, PDprotec®, is designed to improve the outcomes of this treatment and reduce the burden of kidney failure for patients and healthcare providers.
Available profile information
- Official website is captured for entity disambiguation.
- 1 official source linked for verification.
- 1 structured fact available for extraction.
If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.